...
search icon
imnn-img

Imunon Inc Share Price

IMNN
NAQ
$3.25
-$0.02
(-0.61%)
1D
Industry: Biotechnology Sector: Health Care

Imunon Inc Analyst Forecast

Imunon Inc Share Price Chart

Imunon Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$11.12M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
16.75K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.06
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.99 L
$35.84 H
$3.25

About Imunon Inc, Common Stock

Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey. more

Industry: BiotechnologySector: Health Care

Imunon Inc Stock Returns

Time FrameIMNNSectorS&P500
1-Week Return-0.61%-1.08%-1.38%
1-Month Return-14.47%-0.47%-1.81%
3-Month Return-21.88%2.13%1.38%
6-Month Return-51.49%17.04%5.68%
1-Year Return-68.16%6.56%11.74%
3-Year Return-81.27%16.78%65.15%
5-Year Return-99.16%34.34%73.68%
10-Year Return-99.89%137.88%260.03%

Imunon Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue500.00K500.00K500.00K125.00K-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":25,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue11.34M702.92K731.63K720.00K718.12K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":6.2,"profit":true},{"date":"2022-12-31","value":6.45,"profit":true},{"date":"2023-12-31","value":6.35,"profit":true},{"date":"2024-12-31","value":6.33,"profit":true}]
Gross Profit500.00K500.00K500.00K(720.00K)(718.12K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-144,"profit":false},{"date":"2024-12-31","value":-143.62,"profit":false}]
Gross Margin100.00%100.00%100.00%(576.00%)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-576,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses18.99M21.51M25.42M21.03M19.13M[{"date":"2020-12-31","value":74.69,"profit":true},{"date":"2021-12-31","value":84.6,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.73,"profit":true},{"date":"2024-12-31","value":75.26,"profit":true}]
Operating Income(18.49M)(21.01M)(24.92M)(21.03M)(19.13M)[{"date":"2020-12-31","value":-1848641200,"profit":false},{"date":"2021-12-31","value":-2100719000,"profit":false},{"date":"2022-12-31","value":-2492156500,"profit":false},{"date":"2023-12-31","value":-2103043000,"profit":false},{"date":"2024-12-31","value":-1913244600,"profit":false}]
Total Non-Operating Income/Expense(6.07M)(1.70M)(17.12M)1.09M962.42K[{"date":"2020-12-31","value":-559.09,"profit":false},{"date":"2021-12-31","value":-156.36,"profit":false},{"date":"2022-12-31","value":-1576.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":88.66,"profit":true}]
Pre-Tax Income(23.33M)(22.15M)(37.47M)(20.80M)(18.62M)[{"date":"2020-12-31","value":-2332938400,"profit":false},{"date":"2021-12-31","value":-2215269600,"profit":false},{"date":"2022-12-31","value":-3746526000,"profit":false},{"date":"2023-12-31","value":-2079536200,"profit":false},{"date":"2024-12-31","value":-1862024200,"profit":false}]
Income Taxes(1.85M)(1.38M)(1.57M)(1.28M)-[{"date":"2020-12-31","value":-184582300,"profit":false},{"date":"2021-12-31","value":-138344600,"profit":false},{"date":"2022-12-31","value":-156702600,"profit":false},{"date":"2023-12-31","value":-128038500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(21.48M)(20.77M)(35.90M)(19.51M)-[{"date":"2020-12-31","value":-2148356100,"profit":false},{"date":"2021-12-31","value":-2076925000,"profit":false},{"date":"2022-12-31","value":-3589823400,"profit":false},{"date":"2023-12-31","value":-1951497700,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(21.48M)(20.77M)(35.90M)(27.86M)(18.62M)[{"date":"2020-12-31","value":-2148356100,"profit":false},{"date":"2021-12-31","value":-2076925000,"profit":false},{"date":"2022-12-31","value":-3589800000,"profit":false},{"date":"2023-12-31","value":-2785951900,"profit":false},{"date":"2024-12-31","value":-1862024200,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(21.48M)(20.77M)(35.90M)(19.51M)(18.62M)[{"date":"2020-12-31","value":-2148356100,"profit":false},{"date":"2021-12-31","value":-2076925000,"profit":false},{"date":"2022-12-31","value":-3589823400,"profit":false},{"date":"2023-12-31","value":-1951497700,"profit":false},{"date":"2024-12-31","value":-1862024200,"profit":false}]
EPS (Diluted)(10.05)(6.77)(5.17)(2.18)(1.62)[{"date":"2020-12-31","value":-1005,"profit":false},{"date":"2021-12-31","value":-677,"profit":false},{"date":"2022-12-31","value":-517,"profit":false},{"date":"2023-12-31","value":-218,"profit":false},{"date":"2024-12-31","value":-162,"profit":false}]

Imunon Inc Ratios

Imunon Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

IMNN
Cash Ratio 1.25
Current Ratio 1.73

Imunon Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMNN
ROA (LTM) -77.72%
ROE (LTM) -233.50%

Imunon Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMNN
Debt Ratio Lower is generally better. Negative is bad. 0.55
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.45

Imunon Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMNN
Trailing PE NM
Forward PE NM
P/S (TTM) 17.94
P/B 2.72
Price/FCF NM
EV/R 4.00
EV/Ebitda 0.91

FAQs

What is Imunon Inc share price today?

Imunon Inc (IMNN) share price today is $3.25

Can Indians buy Imunon Inc shares?

Yes, Indians can buy shares of Imunon Inc (IMNN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMNN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Imunon Inc be purchased?

Yes, you can purchase fractional shares of Imunon Inc (IMNN) via the Vested app. You can start investing in Imunon Inc (IMNN) with a minimum investment of $1.

How to invest in Imunon Inc shares from India?

You can invest in shares of Imunon Inc (IMNN) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMNN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Imunon Inc shares
What is Imunon Inc 52-week high and low stock price?

The 52-week high price of Imunon Inc (IMNN) is $35.84. The 52-week low price of Imunon Inc (IMNN) is $2.99.

What is Imunon Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Imunon Inc (IMNN) is

What is Imunon Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Imunon Inc (IMNN) is 2.72

What is Imunon Inc dividend yield?

The dividend yield of Imunon Inc (IMNN) is 0.00%

What is the Market Cap of Imunon Inc?

The market capitalization of Imunon Inc (IMNN) is $11.12M

What is Imunon Inc's stock symbol?

The stock symbol (or ticker) of Imunon Inc is IMNN

How Can Investors Use Imunon Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Imunon Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Imunon Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Imunon Inc shares for Indian investors?

When investing in Imunon Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Imunon Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Imunon Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Imunon Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Imunon Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top